D
Demosthenes Bouros
Researcher at National and Kapodistrian University of Athens
Publications - 461
Citations - 25066
Demosthenes Bouros is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Lung cancer. The author has an hindex of 61, co-authored 454 publications receiving 20998 citations. Previous affiliations of Demosthenes Bouros include Boston University & Athens Regional Medical Center.
Papers
More filters
Journal ArticleDOI
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
Ganesh Raghu,Harold R. Collard,Jim J. Egan,Fernando J. Martinez,Juergen Behr,Kevin K. Brown,Thomas V. Colby,Jean-François Cordier,Kevin R. Flaherty,Joseph A. Lasky,David A. Lynch,Jay H. Ryu,Jeffrey J. Swigris,Athol U. Wells,Julio Ancochea,Demosthenes Bouros,Carlos Roberto Ribeiro de Carvalho,Ulrich Costabel,Masahito Ebina,David M. Hansell,Takeshi Johkoh,Dong Soon Kim,Talmadge E. King,Yasuhiro Kondoh,Jeffrey L. Myers,Nestor L. Müller,Andrew G. Nicholson,Luca Richeldi,Moisés Selman,Rosalind F. Dudden,Barbara S. Griss,Shandra Protzko,Holger J. Schünemann +32 more
TL;DR: This document represents the current state of knowledge regarding idiopathic pulmonary fibrosis, and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course.
Journal ArticleDOI
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis,Ulrich Costabel,David M Hansell,Talmadge E. King,David A. Lynch,Andrew G. Nicholson,Christopher J. Ryerson,Jay H. Ryu,Moisés Selman,Athol U. Wells,Jurgen Behr,Demosthenes Bouros,Kevin K. Brown,Thomas V. Colby,Harold R. Collard,Carlos Robalo Cordeiro,Vincent Cottin,Bruno Crestani,Marjolein Drent,Rosalind F. Dudden,Jim Egan,Kevin R. Flaherty,Cory M. Hogaboam,Yoshikazu Inoue,Takeshi Johkoh,Dong Soon Kim,M Kitaichi,James E. Loyd,Fernando J. Martinez,Jeffrey L. Myers,Shandra Protzko,Ganesh Raghu,Luca Richeldi,Nicola Sverzellati,Jeffrey J. Swigris,Dominique Valeyre +35 more
TL;DR: This update is a supplement to the previous 2002 IIP classification document and outlines advances in the past decade and potential areas for future investigation.
Journal ArticleDOI
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu,Martine Remy-Jardin,Jeffrey L. Myers,Luca Richeldi,Christopher J. Ryerson,David J. Lederer,Juergen Behr,Vincent Cottin,Sonye K. Danoff,Ferran Morell,Kevin R. Flaherty,Athol U. Wells,Fernando J. Martinez,Arata Azuma,Thomas Bice,Demosthenes Bouros,Kevin K. Brown,Harold R. Collard,Abhijit Duggal,Liam Galvin,Yoshikazu Inoue,R. Gisli Jenkins,Takeshi Johkoh,Ella A. Kazerooni,Masanori Kitaichi,Shandra L Knight,George Mansour,Andrew G. Nicholson,Sudhakar Pipavath,Ivette Buendía-Roldán,Moisés Selman,William D. Travis,Simon L.F. Walsh,Kevin C. Wilson +33 more
TL;DR: The guideline panel provided recommendations related to the diagnosis of IPF, including a conditional recommendation for multidisciplinary discussion and a strong recommendation against measurement of serum biomarkers for the sole purpose of distinguishing IPF from other ILDs.
Journal ArticleDOI
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
Demosthenes Bouros,Athol U. Wells,Andrew G. Nicholson,Andrew G. Nicholson,Thomas V. Colby,Vlasis Polychronopoulos,Vlasis Polychronopoulos,Panos Pantelidis,Panos Pantelidis,Patricia L Haslam,Patricia L Haslam,Dimitris A. Vassilakis,Dimitris A. Vassilakis,Carol M. Black,Carol M. Black,Roland M. du Bois,Roland M. du Bois +16 more
TL;DR: It is concluded that NSIP is the histopathologic pattern in most patients with FASSc, however, outcome is linked more strongly to disease severity at presentation and serial DL(CO) trends than to histopathological findings.
Journal ArticleDOI
Inhibition and role of let-7d in idiopathic pulmonary fibrosis.
Kusum Pandit,David L. Corcoran,Hanadie Yousef,Manohar Yarlagadda,Argyris Tzouvelekis,Kevin F. Gibson,Kazuhisa Konishi,Samuel A. Yousem,Mandal K. Singh,Daniel Handley,Thomas J. Richards,Moisés Selman,Simon C. Watkins,Annie Pardo,Ahmi Ben-Yehudah,Demosthenes Bouros,Oliver Eickelberg,Prabir Ray,Panayiotis V. Benos,Naftali Kaminski +19 more
TL;DR: The down-regulation of let-7d in IPF and the profibrotic effects of this down- regulation in vitro and in vivo suggest a key regulatory role for this microRNA in preventing lung fibrosis.